Prüfung auf Sterilität nach international harmonisierten Vorschriften Hanfried Seyfarth Abteilung Biopharmazeutische Qualität und Compliance/Mikrobiologie, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss • Applicability • Certain of declaration • Test conditions Environmental controls must be done omn a daily basis (they must be available when deciding about necessity of possible repeat tests). Negative controls: Daily testing as they must be available when deciding about necessity of possible repeat tests. • Duration of incubation • Method validation • Individual Forms of application Unchanged. In USP and JP will be this mandatory, in Ph.Eur. only recommendation. Requirements for bulk are now included. • The amount to be tested Has in part changed (possibly a complete new validation of the method may be required) • Evaluation Repeat tests are only permitted under certain conditions. Aseptic preparations: Repeat test practically impossible. Product sterilises in final container: Chance in identification of organism with more sensitive tests, for example, molecular typing with RNA/DNA homology • The procedure in the case of turbidity of nutrient media Regulation: 14 days incubation of original test and 3 days incubation of subculture. • Nutrient media Unchanged. • Nutrient media controls The possibility of a parametric release are discussed. Key words Europäisches Arzneibuch (Ph.Eur. 4.6) • Steriltest, Anwendbarkeit, Durchführung, Methoden, Neufassung, Validierung |
|
pharmind 2003, Nr. 12, Seite 1263